BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31262330)

  • 1. Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
    Yang B; Wu A; Hu Y; Tao C; Wang JM; Lu Y; Xing R
    J Exp Clin Cancer Res; 2019 Jul; 38(1):283. PubMed ID: 31262330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer.
    Lin S; Zhang Y; Hu Y; Yang B; Cui J; Huang J; Wang JM; Xing R; Lu Y
    Gastric Cancer; 2019 Sep; 22(5):941-954. PubMed ID: 30778796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis.
    Luu Y; Junker W; Rachagani S; Das S; Batra SK; Heinrikson RL; Shekels LL; Ho SB
    Int J Biochem Cell Biol; 2010 Jun; 42(6):996-1006. PubMed ID: 20211273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer.
    Mori Y; Kataoka H; Miura Y; Kawaguchi M; Kubota E; Ogasawara N; Oshima T; Tanida S; Sasaki M; Ohara H; Mizoshita T; Tatematsu M; Asai K; Joh T
    Int J Cancer; 2007 Jul; 121(2):241-7. PubMed ID: 17330845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
    Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
    Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
    Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
    Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer Cells.
    Zhou Y; Xia L; Liu Q; Wang H; Lin J; Oyang L; Chen X; Luo X; Tan S; Tian Y; Su M; Wang Y; Chen P; Wu Y; Wang H; Liao Q
    Cell Physiol Biochem; 2018; 47(4):1399-1410. PubMed ID: 29929193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
    Chen Z; Liu S; Xia Y; Wu K
    Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis.
    Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W
    Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
    Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
    Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways.
    Tu S; Chi AL; Lim S; Cui G; Dubeykovskaya Z; Ai W; Fleming JV; Takaishi S; Wang TC
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1726-37. PubMed ID: 17332476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine.
    Malmberg EK; Pelaseyed T; Petersson AC; Seidler UE; De Jonge H; Riordan JR; Hansson GC
    Biochem J; 2008 Mar; 410(2):283-9. PubMed ID: 17990980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis.
    Li S; Liang X; Ma L; Shen L; Li T; Zheng L; Sun A; Shang W; Chen C; Zhao W; Jia J
    Oncogene; 2018 Feb; 37(7):884-896. PubMed ID: 29059152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane.
    Schneider H; Berger E; Dolan B; Martinez-Abad B; Arike L; Pelaseyed T; Hansson GC
    Biochem J; 2019 Aug; 476(16):2281-2295. PubMed ID: 31387973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.